Long-term obstetric, perinatal, and surgical complications in singleton pregnancies following previous cesarean myomectomy: a retrospective multicentric study

• Published in: Frontiers in surgery Vol. 11; p. 1430439
• Main Authors: Güler, Oğuz, Hatırnaz, Şafak, Sparic, Radmila, Basbug, Alper, Erol, Onur, Kalkan, Üzeyir, Ulubaşoğlu, Hasan, Trojano, Giuseppe, Ürkmez, Sebati Sinan, Tinelli, Andrea
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 01.08.2024
• Subjects: cesarean myomectomy; endometrial myomectomy; myoma recurrence; pregnancy; serosal myomectomy; Surgery; uterine fibroids; myoma recurrence; complications; adhesions; endometrial myomectomy; pregnancy; cesarean myomectomy; uterine fibroids; serosal myomectomy
• ISSN: 2296-875X; 2296-875X
• DOI: 10.3389/fsurg.2024.1430439

The safety of cesarean myomectomy has been proven by previous studies. Our study aimed to reveal the long-term perinatal, obstetric, and surgical outcomes of cesarean myomectomy (CM) by comparing different CM techniques. This retrospective multicentric case-control study involved 7 hospitals and included 226 singleton pregnancies that underwent repeated cesarean section (CS) between 2015 and 2020. Among these pregnancies, 113 of 226 cases had CM (Group A), and 113 had only CS (Group B). Of the 113 cases in which CM was performed, 58 underwent endometrial myomectomy (EM) (Subgroup A1) and 55 underwent serosal myomectomy (SM) (Subgroup A2). The groups were compared in terms of obstetric, perinatal, and surgical outcomes, and fibroid recurrence, myomectomy scar healing rate, and adhesion formation were noted. There was no significant difference between the groups in terms of maternal age, body mass index, gravidity, parity, and fibroid diameter in previous CS (  > 0.05). In the perinatal and obstetric evaluation of the groups, there was no significant difference between the groups in terms of neonatal weight, Apgar score, fetal growth restriction, preterm premature rupture of membranes, preterm delivery, hypertension in pregnancy, and diabetes mellitus (  > 0.05). The fibroid recurrence rate was 28.3%, and the myomectomy scar good healing rate was 99.1%. There was no difference between the groups in terms of CS duration, preoperative and postoperative hemoglobin levels, perioperative blood transfusion rates, febrile morbidity, and prolonged hospitalization (  > 0.05). In terms of adhesion formation, although the adhesion rate of the SM group was higher than that of the EM group, no statistically significant difference was detected between the groups. This study showed that in pregnancies following CM, obstetrical, perinatal, and surgical outcomes were unaffected. Obstetricians can safely use CM, either the trans-endometrial or serosal technique, as it is a safe and effective method with long-term results.